Epidemiology of hepatitis B and C in Germany;Epidemiologie der hepatitis B und C in Deutschland

Medizinische Welt

Volumn 55, Issue 7-8, 2004, Pages 206-210

  Radun, Doris ^a   Hamouda, O ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

Author keywords

Epidemiology; Hepatitis B; Hepatitis C; New comprehensive communicable disease law; Surveillance

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; COOPERATION; FEMALE; GERMANY; HEALTH CARE PERSONNEL; HEALTH SURVEY; HEPATITIS B; HEPATITIS C; HUMAN; INCIDENCE; INFANT; INTRAVENOUS DRUG ABUSE; LABORATORY PERSONNEL; LAW; MAJOR CLINICAL STUDY; MALE; NEWBORN; PUBLIC HEALTH; RISK FACTOR; SEXUAL BEHAVIOR;

EID: 4344691047     PISSN: 00258512     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Lai CL et al. Viral hepatitis B. Lancet 2003, 362: 2089-94.
2. Poynard T et al. Viral hepatitis C. Lancet 2003, 362: 2095-100.
3. Hauri AM, Armstrong GL, Hutin YJF. The global burden of disease attributable to contaminated injections given in health care settings. Int J STD & AIDS 2004; 15: 7-16.
4. Chan CY, Lee SD, Lo KJ. Legend of hepatitis B vaccination: the Taiwan experience. J Gastroenterol Hepatol 2004; 19: 121-6.
5. RKI. Virushepatitis B, C und D: Jahresbericht 2002. Epid Bull 2004; 2: 11-7.
6. Falldefinitionen des Robert Koch-Instituts zur Übermittlung von Erkrankungs- oder Todesfällen und Nachweisen von Krankheitserregern. Ausgabe 2004. http://www.rki.de oder ISBN 3-89606-078-3.
7. Stark K et al. History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection among injecting drug users in Berlin. Int J Epidemiol 1997; 26: 1359-66.
8. Thierfelder W et al. Prevalence of markers for hepatitis A, B and C in the German population. Results of the German National Health Interview and Examination Survey 1998. Europ J Epidemiol 2001; 17: 429-35.
9. RKI. Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut - Stand Juli 2003. Epid Bull 2003; 32: 246-60.
10. RKI. Mitteilung der Ständigen Impfkommission (STIKO) am RKI: Hinweise für Ärzte zum Aufklärungsbedarf bei Schutzimpfungen. Epid Bull 2004; 6: 33-52.
11. Jilg W et al. Prevalence of markers of hepatitis B in the adult German population. J Med Virol 2001; 63: 96-102.
12. Robert Koch-Institut. Infektionsepidemiologisches Jahrbuch für 2003. Berlin 2004. ISBN: 3-89606-085-6.
13. Robert Koch-Institut. Infektionsepidemiologisches Jahrbuch meldepflichtiger Krankheiten für 2002. Berlin 2004. ISBN: 3-89606-041-4.
14. Offergeld R, Stark K, Hamouda O. Infektionen bei Blutspendern. Bundesges.blatt Ges.forsch Ges.schutz 2003; 46: 775-9.
15. Roy K et al. Monitoring hepatitis C virus infection among injecting drug users in the European Union: A review of the literature. Epidemiol Infect 2002; 129: 577-85.
16. Mansson AS et al. Continued transmission of hepatitis B and C viruses, but no transmission of human immunodeficiency virus among intravenous drug users participating in a syringe/needle exchange program. Scand J Infect Dis 2000; 32: 253-8.
17. van Beek I et al. Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: a retrospective cohort study. BMJ 1998; 317: 433-7.